208 related articles for article (PubMed ID: 35971323)
1. Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials.
Zajec V; Mikuš M; Vitale SG; D'alterio MN; Gregov M; Šarić MJ; Carugno J; Angioni S; Ćorić M
Gynecol Endocrinol; 2022 Sep; 38(9):713-720. PubMed ID: 35971323
[TBL] [Abstract][Full Text] [Related]
2. State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.
Mikuš M; Vitale SG; Ćorić M; Zajec V; Ciebiera M; Carugno J; D'alterio MN; Herman M; Puževski T; Angioni S
Gynecol Endocrinol; 2022 Nov; 38(11):911-917. PubMed ID: 36237165
[No Abstract] [Full Text] [Related]
3. Novel pharmacological therapies for the treatment of endometriosis.
Buggio L; Dridi D; Barbara G; Merli CEM; Cetera GE; Vercellini P
Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1039-1052. PubMed ID: 36000243
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis.
Xin L; Ma Y; Ye M; Chen L; Liu F; Hou Q
Arch Gynecol Obstet; 2023 Oct; 308(4):1047-1056. PubMed ID: 36656435
[TBL] [Abstract][Full Text] [Related]
5. Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: a systematic review and network meta-analysis.
Yan H; Shi J; Li X; Dai Y; Wu Y; Zhang J; Gu Z; Zhang C; Leng J
Fertil Steril; 2022 Dec; 118(6):1102-1116. PubMed ID: 36283862
[TBL] [Abstract][Full Text] [Related]
6. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
Clemenza S; Sorbi F; Noci I; Capezzuoli T; Turrini I; Carriero C; Buffi N; Fambrini M; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():92-101. PubMed ID: 29559388
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
Samy A; Taher A; Sileem SA; Abdelhakim AM; Fathi M; Haggag H; Ashour K; Ahmed SA; Shareef MA; AlAmodi AA; Keshta NHA; Shatat HBAE; Salah DM; Ali AS; El Kattan EAM; Elsherbini M
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101798. PubMed ID: 32479894
[TBL] [Abstract][Full Text] [Related]
8. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Rowan JP; Duan WR; Ng J; Schwefel B; Thomas JW; Jain RI; Chwalisz K
N Engl J Med; 2017 Jul; 377(1):28-40. PubMed ID: 28525302
[TBL] [Abstract][Full Text] [Related]
10. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.
Dababou S; Garzon S; Laganà AS; Ferrero S; Evangelisti G; Noventa M; D'Alterio MN; Palomba S; Uccella S; Franchi M; Barra F
Expert Opin Investig Drugs; 2021 Sep; 30(9):903-911. PubMed ID: 34278887
[TBL] [Abstract][Full Text] [Related]
11. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial.
Donnez J; Taylor HS; Taylor RN; Akin MD; Tatarchuk TF; Wilk K; Gotteland JP; Lecomte V; Bestel E
Fertil Steril; 2020 Jul; 114(1):44-55. PubMed ID: 32505383
[TBL] [Abstract][Full Text] [Related]
12. Elagolix for endometriosis: all that glitters is not gold.
Vercellini P; Viganò P; Barbara G; Buggio L; Somigliana E;
Hum Reprod; 2019 Feb; 34(2):193-199. PubMed ID: 30551159
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
[TBL] [Abstract][Full Text] [Related]
14. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.
Ferrero S; Gillott DJ; Venturini PL; Remorgida V
Reprod Biol Endocrinol; 2011 Jun; 9():89. PubMed ID: 21693038
[TBL] [Abstract][Full Text] [Related]
15. Hormonal therapy for endometriosis: from molecular research to bedside.
Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
[TBL] [Abstract][Full Text] [Related]
16. A peek into the drug development scenario of endometriosis - A systematic review.
Goenka L; George M; Sen M
Biomed Pharmacother; 2017 Jun; 90():575-585. PubMed ID: 28407578
[TBL] [Abstract][Full Text] [Related]
17. Pre- and postsurgical medical therapy for endometriosis surgery.
Chen I; Veth VB; Choudhry AJ; Murji A; Zakhari A; Black AY; Agarpao C; Maas JW
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003678. PubMed ID: 33206374
[TBL] [Abstract][Full Text] [Related]
18. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain.
Bedaiwy MA; Allaire C; Yong P; Alfaraj S
Semin Reprod Med; 2017 Jan; 35(1):38-53. PubMed ID: 28002850
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis.
Nawathe A; Patwardhan S; Yates D; Harrison GR; Khan KS
BJOG; 2008 Jun; 115(7):818-22. PubMed ID: 18485158
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study.
Parke S; Gude K; Roth K; Messina F
BMC Womens Health; 2024 Jun; 24(1):353. PubMed ID: 38890641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
